UNSPSC 51192020: Probenecid sodium

This classification denotes a uricosuric agent with the molecular formula C13H18NO4S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FXB45Q4ZVK, chemically known as sodium 4-((dipropylamino)sulfonyl)benzoate, but more generally known as probenecid sodium, which bears US NIH Compound Identifier 32095. European Medicines Agency schedules probenecid sodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10053MIG.

Most nations, for tariff purposes, schedule probenecid sodium under HS 29350090. SMILES: CCCN(CCC)S(=O)(=O)C1CCC(CC1)C(=O)[O-].[NA+].

UNSPSC 51192020 Probenecid sodium is a Commodity code that nominally designates a specific pharmaceutical compound, but recent state and local procurement activity under this code shows a significant mismatch with its abstract scope. The three most recent opportunities posted under this code — Athletic Training Services for Tucson Fire and Police (RFP, due June 9, 2026), Medical Aid Supplies for Tampa Fire Rescue (ITB, due April 9, 2025), and a Request for Information from Texas HHS regarding Direct-to-Manufacturer Prescriptions (RFI, due April 3, 2026) — involve athletic training service delivery, broad medical supply procurement, and pharmacy benefit management program design, respectively. None of these solicitations directly procure probenecid sodium or other pharmaceutical compounds by the unit. The code shows little relevant recent activity aligned with its pharmaceutical-commodity designation; the opportunities appear to have been categorized under this code despite covering service delivery, supply inventory management, and healthcare administration rather than procurement of the specific drug product itself.

Activity under this code spans multiple state and local jurisdictions — the City of Tucson (Arizona), the City of Tampa (Florida), and the Texas Health and Human Services Commission — but the geographic spread and issuing-body mix reflect the underlying mismatch rather than a coherent procurement market. State and local healthcare purchasing offices, fire departments, and health-benefit administrators are using this code, but their actual buying reflects healthcare service contracting and broad-spectrum medical-supply acquisition rather than specialty pharmaceutical procurement. Business development professionals evaluating opportunities under this code should verify the actual commodity or service scope in the RFP or RFQ narrative rather than relying on the UNSPSC code designation alone, as categorization appears inconsistent with the work being bought.